Patrick Amstutz
Founder bei MOLECULAR PARTNERS AG
Vermögen: 3 Mio $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael Tobias Stumpp | M | 52 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 20 Jahre |
William Burns | M | 76 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 7 Jahre |
Vito Palombella | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 Jahre |
Steven Holtzman | M | 70 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 10 Jahre |
Michael Vasconcelles | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 Jahre |
Sandipkumar S. Kapadia | M | 54 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 Jahre |
Dominik Höchli | M | 57 | 3 Jahre | |
Andreas Emmenegger | M | 58 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 17 Jahre |
Gwen A. Fyfe | M | 72 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 5 Jahre |
Agnete Brunsvik Fredriksen | M | 47 | 3 Jahre | |
Seth D. Lewis | M | - | 5 Jahre | |
Daniel Steiner | M | - | 13 Jahre | |
Alexander Zürcher | M | - | 2 Jahre | |
Philippe Legenne | M | - | 4 Jahre | |
Renate Gloggner | F | - | 3 Jahre | |
Jurgi Camblong | M | 45 |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
Baris Arican | M | - | 2 Jahre | |
Robert Kuster | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
Michael Altorfer | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | 6 Jahre |
Michael Pitzner | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Patrik Forrer | M | - | - | |
Christian Zahnd | M | 49 | 12 Jahre | |
Dominik Escher | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
Andreas Plückthun | M | 65 | - | |
Göran Albert Ando | M | 75 | 10 Jahre | |
William Lee | M | 69 | 13 Jahre | |
Jeffrey H. Buchalter | M | 67 | 2 Jahre | |
Jörn Aldag | M | 65 | 11 Jahre | |
Petri T. Vainio | M | 65 | 11 Jahre | |
Pamela A. Trail | M | 68 | 1 Jahre | |
Martin Kawe | M | - | - | |
Kaspar Binz | M | - | - | |
Andreas Harstrick | M | 63 | 4 Jahre | |
Lisa Rojkjaer | M | 58 | - | |
Nicolas Leupin | M | 50 | 4 Jahre | |
Julien Gander | M | 45 | 6 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 36 | 100,00% |
Vereinigte Staaten | 8 | 22,22% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Patrick Amstutz
- Persönliches Netzwerk